CEN Biotech, Inc. (CENBF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CEN Biotech, Inc. (CENBF) trades at $0.00 with AI Score 61/100 (Grade B+). CEN Biotech, Inc. is a Canadian company focused on the development of LED lighting technology and hemp-based products. Market cap: $6,526, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for CENBF: CENBF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CENBF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
CENBF: 2/4 perspectives are bullish. Dominant signal: Seth Klarman bearish.
How is this calculated? →CEN Biotech, Inc. (CENBF) Healthcare & Pipeline Overview
CEN Biotech, Inc. specializes in the manufacture and development of LED lighting technology and hemp-based products, positioning itself within the growing healthcare sector focused on industrial and medical applications.
What Is the Investment Thesis for CENBF?
CEN Biotech, Inc. operates in a niche market focusing on LED technology and hemp-based products, which are gaining traction due to their sustainability and health benefits. The company’s gross margin stands at 50.5%, indicating a potential for profitability as it scales operations. With the increasing legalization and acceptance of hemp products in various sectors, CEN Biotech is well-positioned to capitalize on this trend. However, the company faces challenges, including a negative profit margin of -153.5%, which necessitates careful management of its operational costs. The company's growth will depend on its ability to expand its product offerings and market reach while managing risks associated with the volatile hemp market.
Based on FMP financials and quantitative analysis
CENBF Key Highlights
- Gross margin of 50.5% indicates strong potential for profitability as operations scale.
- Negative profit margin of -153.5% highlights the need for cost management and operational efficiency.
- Market Cap is currently at $0.00B, reflecting the early-stage nature of the business.
- Small workforce of 4 employees allows for agile decision-making and adaptation to market changes.
- Focus on both LED technology and hemp products diversifies revenue streams.
Who Are CENBF's Competitors?
CENBF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CURLF Curaleaf Holdings, Inc. | $9.60 | -6.20% | $2.54B | 53 |
| APHA APHA | $15.27 | -1.04% | 56 | |
| TLRY Tilray Brands, Inc. | $4.37 | -5.36% | $524.68M | 47 |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| NPNKF Nippon Shinyaku Co., Ltd. | $32.75 | +4.30% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CENBF's Key Strengths?
- Strong gross margin of 50.5% indicates potential profitability.
- Diverse product offerings in both LED and hemp markets.
- Agile business model with a small workforce.
What Are CENBF's Weaknesses?
- Negative profit margin of -153.5% necessitates operational improvements.
- Limited brand recognition in a competitive market.
- Small team may limit scalability.
What Could Drive CENBF Stock Higher?
- Expansion into new markets for hemp-based products as legalization increases.
- Development of LED lighting technology to meet growing demand for energy-efficient solutions.
- Digital marketing and web design services to enhance brand visibility and customer acquisition.
What Are the Key Risks for CENBF?
- Financial-distress signal — its Altman Z-Score of -9.90 sits in the distress zone (elevated bankruptcy risk).
- Regulatory changes affecting the hemp market could impact operations.
- Competition in the LED and hemp sectors may pressure margins.
- Market volatility in hemp prices could affect profitability.
What Are the Growth Opportunities for CENBF?
- Growth opportunity 1: The global hemp market is projected to reach $26.6 billion by 2025, driven by increasing demand for hemp-based products in food, cosmetics, and pharmaceuticals. CEN Biotech's cultivation of hemp for industrial and medical use positions it to capture a share of this expanding market, particularly as consumer preferences shift towards natural ingredients.
- Growth opportunity 2: The LED lighting market is expected to grow to $105 billion by 2025, fueled by advancements in technology and a shift towards energy-efficient solutions. CEN Biotech's focus on LED technology can leverage this trend, particularly in sectors requiring sustainable lighting solutions.
- Growth opportunity 3: The increasing legalization of hemp and cannabis products across various jurisdictions presents a significant opportunity for CEN Biotech. As regulations become more favorable, the company can expand its product offerings and market reach, tapping into new customer segments.
- Growth opportunity 4: Digital marketing and web design services offered by CEN Biotech can provide an additional revenue stream. With the rise of e-commerce and online presence, businesses are increasingly seeking digital marketing solutions, allowing CEN Biotech to capitalize on this trend.
- Growth opportunity 5: Collaborations and partnerships with other companies in the healthcare and agriculture sectors can enhance CEN Biotech's product development and market penetration. By aligning with established players, the company can leverage shared resources and expertise to accelerate growth.
What Opportunities Does CENBF Have?
- Expanding hemp market projected to reach $26.6 billion by 2025.
- Growth in LED lighting market expected to reach $105 billion.
- Increasing legalization of hemp products opens new markets.
What Threats Does CENBF Face?
- Intense competition in both LED and hemp sectors.
- Regulatory uncertainties surrounding hemp cultivation.
- Market volatility affecting hemp prices.
What Are CENBF's Competitive Advantages?
- Focus on innovative and sustainable product offerings.
- Small team allows for quick adaptation to market changes.
- Diverse revenue streams mitigate risks associated with market fluctuations.
- Niche positioning in the growing hemp market.
- Expertise in both technology and agriculture sectors.
What Does CENBF Do?
CEN Biotech, Inc. was incorporated in 2013 and is headquartered in Windsor, Canada. The company focuses on the manufacture, production, and development of light-emitting diode (LED) lighting technology alongside hemp-based products intended for industrial, medical, and food applications. CEN Biotech aims to leverage the growing demand for hemp-derived products, which are increasingly recognized for their potential health benefits and versatility in various industries. The company also offers digital marketing and web design services, further diversifying its business model. With a small team of four employees, CEN Biotech is positioned to adapt quickly to market changes and innovations. As the healthcare sector evolves, the demand for sustainable and innovative solutions, such as those offered by CEN Biotech, is likely to increase, providing the company with potential growth avenues. The company’s dual focus on technology and agricultural products allows it to tap into multiple revenue streams, catering to a diverse clientele.
What Products and Services Does CENBF Offer?
- Manufacture and develop LED lighting technology.
- Cultivate hemp for industrial, medical, and food applications.
- Provide digital marketing and web design services.
- Focus on sustainable and innovative product offerings.
- Serve diverse customer segments across multiple industries.
- Adapt to market changes with a small, agile team.
How Does CENBF Make Money?
- Generate revenue through the sale of LED lighting products.
- Cultivate and sell hemp-based products to various sectors.
- Offer digital marketing and web design services to businesses.
- Leverage market trends in sustainability and health.
- Diversify revenue streams to reduce dependency on a single market.
What Industry Does CENBF Operate In?
The healthcare industry, particularly in the drug manufacturing sector, is experiencing significant growth driven by increasing consumer demand for natural and sustainable products. The market for hemp-derived products is projected to expand rapidly, with a growing acceptance of cannabis-based therapies across various regions. CEN Biotech, Inc. is positioned within this evolving landscape, where competition is intensifying as more companies enter the hemp market. The drug manufacturers' segment is expected to see a compound annual growth rate (CAGR) of over 15% in the coming years, driven by innovation and regulatory changes. CEN Biotech's focus on both LED technology and hemp products allows it to tap into multiple growth avenues within the healthcare sector.
Who Are CENBF's Key Customers?
- Businesses seeking LED lighting solutions.
- Industrial clients requiring hemp for manufacturing.
- Medical companies looking for hemp-derived products.
- Food producers interested in hemp ingredients.
- Companies needing digital marketing and web design services.
Company Profile
CEN Biotech, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Windsor, CA. The company is led by CEO Brian S. Payne. CENBF has traded publicly since 2020.
F-Score 5/9Financial Health
CEN Biotech, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -9.90 places it in the distress zone, a signal of elevated financial risk.
ROE 77%Key Financial Metrics
Return on equity for CEN Biotech, Inc. stands at 76.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -19.3%, showing how much profit it generates from its asset base. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching.
CENBF Valuation & Market Position
With a 7K market cap, CEN Biotech, Inc. sits in the micro-cap segment of the market. Relative to its peer group, CENBF's quantitative score of 61/100 is roughly in line with the peer average of 59/100.
CENBF Financials
Bull Case vs Bear Case
Bull Case
- Strong gross margin of 50.5% indicates potential profitability.
- Diverse product offerings in both LED and hemp markets.
- Agile business model with a small workforce.
- Upcoming: Expansion into new markets for hemp-based products as legalization increases.
Bear Case
- Negative profit margin of -153.5% necessitates operational improvements.
- Limited brand recognition in a competitive market.
- Small team may limit scalability.
- Potential: Regulatory changes affecting the hemp market could impact operations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CENBF Latest News
No recent news available for CENBF.
CENBF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CENBF.
Price Targets
Wall Street price target analysis for CENBF.
CENBF MoonshotScore
What does this score mean?
The MoonshotScore rates CENBF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Brian S. Payne
CEO
Brian S. Payne has been at the helm of CEN Biotech, Inc. since its inception in 2013. With a background in business management and technology, he has guided the company through its early stages of development. His experience encompasses various roles in the healthcare and technology sectors, providing him with a unique perspective on market dynamics.
Track Record: Under Brian's leadership, CEN Biotech has established itself in the niche markets of LED technology and hemp products. His strategic decisions have focused on product innovation and market expansion, positioning the company to capitalize on emerging trends.
CENBF OTC Market Information
The OTC Other tier includes companies that do not meet the stringent listing requirements of major exchanges like NYSE or NASDAQ. This tier allows for greater flexibility but may involve higher risks due to less regulatory oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures may lead to uncertainty regarding the company's financial health.
- Lower liquidity can result in higher volatility and difficulty in executing trades.
- Regulatory risks associated with operating in the hemp market.
- Verify the company's financial statements and disclosures.
- Assess the management team's experience and track record.
- Investigate the competitive landscape and market positioning.
- Review regulatory compliance related to hemp cultivation.
- Evaluate the company's growth strategy and market opportunities.
- Incorporated in 2013, indicating a level of operational stability.
- Focus on innovative technologies and sustainable products.
- Engagement in multiple revenue streams reduces dependency on a single market.
CENBF Healthcare Stock FAQ
What does CEN Biotech, Inc. do?
CEN Biotech, Inc. specializes in the manufacture and development of LED lighting technology and hemp-based products. The company aims to cultivate hemp for industrial, medical, and food applications while also providing digital marketing and web design services. This dual focus allows CEN Biotech to serve diverse customer segments and adapt to market demands.
What are the main risks for CENBF?
CEN Biotech, Inc. faces several risks, including regulatory uncertainties surrounding the hemp market, which could impact its operations. Additionally, intense competition in both the LED and hemp sectors may pressure profit margins. Market volatility in hemp prices poses another risk, potentially affecting the company's profitability and financial stability.
What revenue streams does CEN Biotech, Inc. have in healthcare?
CEN Biotech, Inc. generates revenue through multiple streams, including the sale of LED lighting products, cultivation and sale of hemp-based products, and offering digital marketing and web design services. This diversified approach allows the company to tap into various sectors, including industrial, medical, and food markets, enhancing its overall revenue potential.
What are the key factors to evaluate for CENBF?
CEN Biotech, Inc. (CENBF) holds an AI score of 61/100 (moderate). Not financial advice.
How frequently does CENBF data refresh on this page?
CENBF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CENBF's recent stock price performance?
CEN Biotech, Inc. (CENBF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong gross margin of 50.5% indicates potential profitability. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CENBF overvalued or undervalued right now?
Valuing CEN Biotech, Inc. (CENBF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CENBF?
Before investing in CEN Biotech, Inc. (CENBF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial disclosures may affect the reliability of financial assessments.